Common Equity: The sum of all common equity items.
Sionna Therapeutics, Inc. (SION) had Common Equity of $321.67M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-20.28M |
|
-- |
|
-- |
|
$23.80M |
|
$-23.80M |
|
$3.53M |
|
$-20.28M |
|
$-20.28M |
|
$-20.28M |
|
$-20.28M |
|
$-20.28M |
|
$-20.28M |
|
$-23.80M |
|
$-24.45M |
|
44.26M |
|
44.26M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$252.33M |
|
$2.14M |
|
$86.94M |
|
$339.27M |
|
$9.85M |
|
-- |
|
$7.75M |
|
$17.60M |
|
|
Common Equity |
$321.67M |
$321.67M |
|
$321.67M |
|
44.46M |
|
| Cash Flow Statement Financials | |
$-49.67M |
|
$-141.34M |
|
$204.05M |
|
$38.75M |
|
$51.79M |
|
$13.04M |
|
$8.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
25.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.30% |
|
-6.30% |
|
-5.98% |
|
-6.30% |
|
$7.23 |
|
$-1.13 |
|
$-1.12 |
|